Desmosine is a predictor of long-term cardiovascular mortality in bronchiectasis

J. Huang (Dundee (Angus), United Kingdom), E. Kuzmanova (Dundee (Angus), United Kingdom), A. Dicker (Dundee (Angus), United Kingdom), H. Keir (Dundee (Angus), United Kingdom), S. Finch (Dundee (Angus), United Kingdom), S. Aliberti (MIlan, Italy), T. Fardon (Dundee (Angus), United Kingdom), J. Chalmers (Dundee (Angus), United Kingdom)

Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases
Session: New biomarkers for management of obstructive diseases
Session type: Oral Presentation
Number: 4718

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Huang (Dundee (Angus), United Kingdom), E. Kuzmanova (Dundee (Angus), United Kingdom), A. Dicker (Dundee (Angus), United Kingdom), H. Keir (Dundee (Angus), United Kingdom), S. Finch (Dundee (Angus), United Kingdom), S. Aliberti (MIlan, Italy), T. Fardon (Dundee (Angus), United Kingdom), J. Chalmers (Dundee (Angus), United Kingdom). Desmosine is a predictor of long-term cardiovascular mortality in bronchiectasis. 4718

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tiotropium and the risk of cardiovascular events and all-cause mortality
Source: Annual Congress 2010 - Comorbidities and disease management in primary care
Year: 2010

MPAP/CO-slope during exercise as predictor of mortality in patients at risk for pulmonary hypertension.
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020


Prior cardiovascular disease increases long-term mortality in COPD patients with pneumonia
Source: Eur Respir J 2014; 43: 36-42
Year: 2004



COPD the unseen factor causing increased morbidity and mortality among IHD patients
Source: Annual Congress 2009 - COPD case-finding and management in primary care
Year: 2009



No impact of statins on time to first COPD exacerbation or all-cause mortality
Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data
Year: 2021

Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD
Source: Eur Respir J 2016; 47:1365-1373
Year: 2016



The natural history of COPD without co-morbidities: predictors of long-term mortality
Source: Annual Congress 2009 - Biomarkers, comorbidities and prognosis of COPD
Year: 2009



Factors affecting mortality and morbidity in patients with bronchiectasis
Source: Annual Congress 2010 - Lung morbidity on exposure to various agents
Year: 2010

Predictors of mortality in COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009


Predictors of mortality in COPD
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008

Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020
Year: 2021



The impact on risk-factor analysis of different mortality outcomes in COPD patients
Source: Eur Respir J 2008; 32: 629-636
Year: 2008



Co-morbidities and cardiovascular medications are the best predictors of mortality in patients with obesity-associated hypoventilation treated with long-term non-invasive ventilation
Source: Annual Congress 2012 - Current trends in home mechanical ventilation
Year: 2012


hsCRP is associated with 10-year mortality in COPD.
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020


Correlates and assessment of excess cardiovascular risk in bronchiectasis
Source: Eur Respir J, 50 (5) 1701127; 10.1183/13993003.01127-2017
Year: 2017



Long-term impact of COPD on postoperative cardiorespiratory morbidity and mortality: a population cohort study
Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases
Year: 2021



Mortality in bronchiectasis: a long-term study assessing the factors influencing survival
Source: Eur Respir J 2009; 34: 843-849
Year: 2009



Impact of intermittent hypoxia on cardiovascular morbidity and mortality
Source: Research Seminar 2005 - Adaptations to Hypoxia
Year: 2005


Hyperglycemia as a independent predictor of mortality in acute pulmonary embolism
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011

Association of symptom subtypes and obstructive sleep apnoea-specific hypoxic burden with cardiovascular morbidity and all-cause mortality
Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders
Year: 2021